Skip to main content

CORRECTION article

Front. Immunol., 30 October 2023
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
This article is part of the Research Topic Community Series in Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-based Therapies in the Management of Inflammatory Rheumatic Diseases: Volume II View all 9 articles

Corrigendum: Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity

Yiwei Shen&#x;Yiwei Shen1†Kamala Vanarsa&#x;Kamala Vanarsa2†Zhihua Yin,&#x;Zhihua Yin3,4†Ting Zhang,Ting Zhang2,5Jessica CastilloJessica Castillo2Min DaiMin Dai1Linghua Zou,Linghua Zou3,6Ling QinLing Qin7Jieying WangJieying Wang8Qiang GuoQiang Guo1Ramesh SaxenaRamesh Saxena9Michelle PetriMichelle Petri10Nan Shen,,,,Nan Shen1,3,11,12,13Zhizhong Ye,*Zhizhong Ye3,4*Chandra Mohan*Chandra Mohan2*Huihua Ding*Huihua Ding1*
  • 1Department of Rheumatology, Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • 2Department of Biomedical Engineering, University of Houston, Houston, TX, United States
  • 3Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China
  • 4Department of Rheumatology, Joint Research Laboratory for Rheumatology of Shenzhen University Health Science Center and Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China
  • 5Division of Rheumatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China
  • 6Department of Rehabilitation, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China
  • 7Department of Nephrology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
  • 8Clinical Research Unit, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • 9Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, TX, United States
  • 10Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
  • 11State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine (SJTUSM), Shanghai, China
  • 12Center for Autoimmune Genomics and Etiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States
  • 13Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States

A Corrigendum on
Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity

by Shen Y, Vanarsa K, Yin Z, Zhang T, Castillo J, Dai M, Zou L, Qin L, Wang J, Guo Q, Saxena R, Petri M, Shen N, Ye Z, Mohan C and Ding H (2023) Front. Immunol. 14:1200167. doi: 10.3389/fimmu.2023.1200167

In the published article, there was an error. In the results section of the abstract, there is an error in the statement.

A correction has been made to the Abstract, Results section, Sentence 2. This sentence previously stated:

“uL-selectin positively correlated with global and renal disease activities as well as histological activity index and chronicity index (CI).”

The corrected sentence appears below:

“uL-selectin positively correlated with global and renal disease activities and was significantly associated with histological activity index and chronicity index (CI).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: lupus nephritis, L-selectin, urinary biomarker, renal histopathology, treatment response

Citation: Shen Y, Vanarsa K, Yin Z, Zhang T, Castillo J, Dai M, Zou L, Qin L, Wang J, Guo Q, Saxena R, Petri M, Shen N, Ye Z, Mohan C and Ding H (2023) Corrigendum: Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity. Front. Immunol. 14:1295153. doi: 10.3389/fimmu.2023.1295153

Received: 15 September 2023; Accepted: 24 October 2023;
Published: 30 October 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Shen, Vanarsa, Yin, Zhang, Castillo, Dai, Zou, Qin, Wang, Guo, Saxena, Petri, Shen, Ye, Mohan and Ding. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Huihua Ding, dinghuihua@outlook.com; Chandra Mohan, cmohan@central.uh.edu; Zhizhong Ye, yezhizhong@126.com

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.